# Merck & Co., Inc. (MRK) — Q1-2024 Earnings Results

**Report date:** 2024-04-25 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/MRK/earnings/Q1-2024

## Post-Earnings Brief

### Headline

Merck Beats on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.07 | N/A | +6.92% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering value through our pipeline.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Merck's earnings report shows a positive surprise in EPS, indicating strong performance in that area. However, the lack of revenue data and guidance may leave investors uncertain about future growth. The stock reaction is currently unavailable, which makes it difficult to gauge market sentiment following the announcement.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/MRK/earnings/Q1-2024_